MapLight Therapeutics (MPLT) Financials: Revenue & Earnings

MPLT price $8.02 -0.15 -1.84%

Ticker
MPLT
Price
$8.02
Change
-0.15 -1.84%
Market cap ?
$341.80M
Beta ?
2.77
Sector
Healthcare
Industry
Biotechnology

Fair value

MPLT fair value Not meaningful. Price $8.02.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare MPLT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-12-03—-1.22——
2026-09-18-1.32-1.35——
2026-08-13-1.32-1.35——
2026-05-15-1.34-1.05——
2025-12-04-37.18-1.72——
2025-08-22-1.14-0.96——
2025-07-30-0.54———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-15Kreitzer AnatolSell12.25K$7.8496.02K
2026-10-15GILLIS JONATHANSell10.17K$8.0882.15K
2026-10-15Lillie James WoodruffSell11.51K$8.0893.03K
2026-10-15Hanson KristopherSell9.02K$8.0872.88K
2026-10-15Foff Erin PennockSell15.36K$8.08124.07K
2026-10-15Kroeger Christopher A.Sell73.69K$8.08595.42K
2026-09-16Hanson KristopherSell16.51K$11.67192.66K
2026-08-17Kreitzer AnatolBuy6.02K——
2026-08-17Kreitzer AnatolBuy24.45K$11.24275.00K
2026-08-17GILLIS JONATHANBuy2.22K——
2026-08-17GILLIS JONATHANBuy6.02K——
2026-08-17GILLIS JONATHANBuy24.45K$11.24275.00K
2026-08-17GILLIS JONATHANBuy2.81K$11.2431.63K
2026-08-17Lillie James WoodruffBuy7.73K——
2026-08-17Lillie James WoodruffBuy31.39K$11.24353.04K
2026-08-17Hanson KristopherBuy7.73K——
2026-08-17Hanson KristopherBuy31.39K$11.24353.04K
2026-08-17Foff Erin PennockBuy13.36K——
2026-08-17Foff Erin PennockBuy54.24K$11.24609.93K
2026-08-17Kroeger Christopher A.Buy23.14K——
2026-08-17Kroeger Christopher A.Buy93.95K$11.241.06M
2026-08-14Catalyst4, Inc.Buy4.40M$11.3850.07M
2026-08-14Catalyst4, Inc.Buy2.93M$0.00293
2026-08-03Lillie James WoodruffSell22.08K$12.54276.91K
2026-07-30Catalyst4, Inc.Buy1.00M$13.0013.00M
2026-07-29Catalyst4, Inc.Buy3.00K$12.6337.89K
2026-07-28Catalyst4, Inc.Buy65.14K$11.69761.39K
2026-07-28Catalyst4, Inc.Buy141.09K$10.741.52M
2026-07-28Cox TroyBuy15.62K$9.52148.70K
2026-07-17GILLIS JONATHANSell600$36.5121.91K
2026-07-17GILLIS JONATHANSell16.97K$37.61638.20K
2026-07-17GILLIS JONATHANSell900$38.1734.35K
2026-07-17Kreitzer AnatolSell2.83K$37.05104.96K
2026-07-17Kreitzer AnatolSell14.14K$37.70533.08K
2026-07-17Kreitzer AnatolSell200$38.397.68K
2026-07-17Kroeger Christopher A.Sell16.78K$37.90635.92K
2026-07-17Lillie James WoodruffSell2.08K$37.9078.72K
2026-07-17Hanson KristopherSell1.13K$37.9042.83K
2026-07-17Foff Erin PennockSell3.66K$37.90138.56K
2026-07-16GILLIS JONATHANSell6.98K$36.66255.85K
2026-07-16GILLIS JONATHANSell1.48K$37.4455.26K
2026-07-16Kreitzer AnatolSell7.46K$36.66273.63K
2026-07-16Kreitzer AnatolSell1.59K$37.4459.60K
2026-07-16Kroeger Christopher A.Sell40.90K$36.461.49M
2026-07-16Kroeger Christopher A.Sell28.09K$37.261.05M
2026-07-16Kroeger Christopher A.Sell92$37.963.49K
2026-07-16Lillie James WoodruffSell5.01K$36.45182.58K
2026-07-16Lillie James WoodruffSell3.53K$37.26131.38K
2026-07-16Lillie James WoodruffSell12$37.96456
2026-07-16Hanson KristopherSell4.78K$36.45174.09K
2026-07-16Hanson KristopherSell3.33K$37.26124.11K
2026-07-16Hanson KristopherSell11$37.96418
2026-07-16Foff Erin PennockSell9.16K$36.46334.08K
2026-07-16Foff Erin PennockSell5.87K$37.26218.53K
2026-07-16Foff Erin PennockSell19$37.96721
2026-07-15GILLIS JONATHANSell5.36K$36.13193.51K
2026-07-15GILLIS JONATHANSell4.70K$36.94173.58K
2026-07-15Kreitzer AnatolSell5.54K$36.13200.34K
2026-07-15Kreitzer AnatolSell4.51K$36.94166.60K
2026-07-15Kroeger Christopher A.Sell18.95K$36.00682.20K
2026-07-15Kroeger Christopher A.Sell42.74K$36.991.58M
2026-07-15Kroeger Christopher A.Sell90$37.543.38K
2026-07-15Lillie James WoodruffSell2.24K$36.0080.57K
2026-07-15Lillie James WoodruffSell5.39K$36.99199.49K
2026-07-15Lillie James WoodruffSell12$37.54450
2026-07-15Hanson KristopherSell2.15K$36.0077.29K
2026-07-15Hanson KristopherSell5.10K$36.99188.76K
2026-07-15Hanson KristopherSell10$37.54375
2026-07-15Foff Erin PennockSell7.16K$36.16258.72K
2026-07-15Foff Erin PennockSell7.84K$37.04290.58K
2026-07-15Foff Erin PennockSell4.46K$36.00160.74K
2026-07-15Foff Erin PennockSell8.97K$36.99331.87K
2026-07-15Foff Erin PennockSell18$37.54676
2026-06-23Cox TroyBuy29.80K$28.64853.59K
2026-06-23Cox TroyBuy7.86K——
2026-06-23Babler MartinBuy29.80K$28.64853.59K
2026-06-23Babler MartinBuy7.86K——
2026-06-23Garnett Timothy JohnBuy3.93K——
2026-06-23Garnett Timothy JohnBuy14.90K$28.64426.79K
2026-06-23Luneborg Nanna LiebachBuy14.90K$28.64426.79K
2026-06-23Luneborg Nanna LiebachBuy3.93K——
2026-06-23Pavlov GeorgeBuy3.93K——
2026-06-23Pavlov GeorgeBuy14.90K$28.64426.79K
2026-06-23Walker Maria CBuy3.93K——
2026-06-23Walker Maria CBuy14.90K$28.64426.79K
2026-06-23Cox TroyOther0——
2026-06-23Babler MartinOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 110, holders +29 vs prior quarter. Ownership 58.29%.

HolderSharesChangeChange %Value
NOVO HOLDINGS A/S3.69M00.00%132.13M
FCPM III SERVICES B.V.3.23M00.00%115.63M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.2.78M-20.21K-0.72%99.70M
GOLDMAN SACHS GROUP INC1.95M-46.56K-2.33%69.83M
PRICE T ROWE ASSOCIATES INC /MD/1.42M1.31M+1162.50%51.00M
BLACKROCK, INC.1.03M-314.60K-23.48%36.74M
NAN FUNG GROUP HOLDINGS LTD971.25K00.00%34.81M
5AM VENTURE MANAGEMENT, LLC950.01K00.00%34.05M
SANOFI912.04K00.00%32.69M
STATE STREET CORP852.15K513.03K+151.29%30.54M
FMR LLC823.56K619.05K+302.71%29.52M
VANGUARD CAPITAL MANAGEMENT LLC784.15K64.33K+8.94%28.10M
BLUE OWL CAPITAL HOLDINGS LP729.93K-276.00K-27.44%26.16M
PARADIGM BIOCAPITAL ADVISORS LP685.85K685.85KNew24.58M
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC611.45K-1-0.00%21.91M
VELAN CAPITAL INVESTMENT MANAGEMENT LP492.89K00.00%17.67M
SIREN, L.L.C.450.00K00.00%16.13M
CAPITAL WORLD INVESTORS415.73K415.73KNew14.90M
GEODE CAPITAL MANAGEMENT, LLC402.05K-79.15K-16.45%14.41M
BAKER BROS. ADVISORS LP364.70K00.00%13.07M
DAFNA CAPITAL MANAGEMENT LLC171.01K00.00%6.13M
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A.170.86K-96.88K-36.19%6.12M
FREESTONE GROVE PARTNERS LP168.91K-145.04K-46.20%6.05M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC136.82K-24.33K-15.10%4.90M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.136.82K136.82KNew4.90M

Earnings and financials

MapLight Therapeutics, Inc. (MPLT) trades at $8.02, with a market cap of $341.80M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

MapLight Therapeutics (MPLT) Financials: Revenue & Earnings

MPLT$8.02-0.15 -1.84%

$341.80M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History